Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the la

Conduction Vaporizers Global Market Report 2023: Increased Adoption of Safer Substitutes for Cigarettes Bolsters Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Conduction Vaporizers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031” report has been added to ResearchAndMarkets.com’s offering. The global conduction vaporizers market is expected to grow at a CAGR of 15% during the forecast period of 2023 to 2031. As more individuals learn about the health benefits of vaporization and the dangers of smoking, the demand for vaporize

Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2023 ended February 28, 2023, on Tuesday, April 11, 2023, after market close. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, April 12, 2023 Time: 8:00 am Eastern Ti

Global Gastrointestinal Agents Industry Report to 2030: North America Dominates the Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Agents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The report offers strategic insights into the overall gastrointestinal agents market along with the market size and estimates for the duration 2020 to 2030. Companies Mentioned Abbott Laboratories Allergan Plc. (Formerly Actavis Plc.) Ast

Delic Holdings Corp. Signs LOI with Peter/PetraMD to Acquire Ketamine Wellness Centers and Facilitate Online Ketamine Treatments Nationwide

VANCOUVER, British Columbia–(BUSINESS WIRE)–Peter/PetraMD, the largest online provider of hormone therapy for men and women in the United States, today announced the intent to acquire Ketamine Wellness Centers. If successful, the acquisition would represent an incredible on-ramp into the ketamine space for Peter/PetraMD. With over 20 years of experience and nearly 100,000 patients across the United States, Ketamine Wellness Centers is the largest ketamine infusion therapy provider in the US a

Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

BOSTON–(BUSINESS WIRE)–The following Eaton Vance closed-end funds (the “Funds”) announced distributions today as detailed below. Declaration – 4/3/2023 Ex-Date – 4/12/2023 Record – 4/13/2023 Payable – 4/20/2023   Municipal Bond Funds: Fund Ticker Distribution Change From Prior Distribution Closing Market Price – 3/31/23 Distribution Rate at Market Price Eaton Vance California Municipal Income Trust CEV $0.0371 – $10.23 4.35% Eaton Vance Municipal Income Trust EVN $0.0410 – $10.13 4.86%     Ta

Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2022. “Enveric is a transformed company; 2022 was a year of considerable accomplishments, and we are now poised for an a

Smithers Announces Vice President of Operations, North America, Environmental Risk Sciences Division

WAREHAM, Mass.–(BUSINESS WIRE)– #ecotoxicology–Smithers, a leading provider of testing, consulting, information, and compliance services, announces the appointment of Glen (Gus) Zieske as Vice President, North America, Environmental Risk Sciences Division. In this role, Gus will have leadership responsibilities for the Smithers North American team of experts who provide environmental testing services in the areas of ecotoxicology, environmental fate, plant and animal metabolism, and product and residue chemi

Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announced its annual results for the year to December 31, 2022. Pier Vincenzo Piazza, CEO of Aelis Farma, said: “2022 was marked by a number of key events for Aelis Farma, beginning with our IPO, which enabled us to raise substantial financial resour

Tenet to Report its First Quarter 2023 Results on April 25th

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2023 results before the market opens on Tuesday, April 25, 2023, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services comp

POSaBIT Acquires Payments Solutions Provider Hypur for US$7.5 Million, Adding Over US$100 Million in Annualized Payment GMV

TORONTO & SEATTLE–(BUSINESS WIRE)–POSaBIT Systems Corporation (“POSaBIT” or the “Company”) (CSE: PBIT, OTC: POSAF), a premier point-of-sale and payments provider for the cannabis industry, today announced it has acquired certain assets from Hypur Inc. (“Hypur”), effective April 1, 2023, in a cash and equity transaction valued at up to US$7.5 million, implying a purchase price multiple of 1.4x 2022 revenue.1 Hypur is a leading provider of compliant, sustainable payment and bank compliance solu